Powered by: Motilal Oswal

News

Zydus Wellness gains on reporting 9% rise in Q4 consolidated net profit Zydus Wellness is currently trading at Rs. 1491.00, up by 9.00 points or 0.61% from its previous closing of Rs. 1482.00 on the BSE. The scrip opened at Rs. 1498.00 and has touched a high and low of Rs. 1498.00 and Rs. 1475.70 respectively. So far 889 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1791.15 on 02-Nov-2022 and a 52 week low of Rs. 1363.85 on 02-Feb-2023. Last one week high and low of the scrip sto...
Zydus Wellness gains on reporting 9% rise in Q4 consolidated net profit
Zydus Wellness gains on reporting 9% rise in Q4 consolidated net profit
Source: Accord Fintech
18/05/2023 11:42:15 AM
Buy Zydus Wellness Ltd For Target Rs.2,000 - ICICI Securities A forgettable quarter in terms of margins while focus continues on laying building blocks Zydus reported a decent (though below potential) top-line and volume growth prints of 12% and 5%, respectively. Gross margins were down 490bps YoY due to sharp inflation in milk prices and weak product mix. Continued brand investments and higher other opex lead to dismal EBITDA margin print of 3.8%. We note that Zydus probably has higher distribution expansion benefit (compared to peers), which is not...
Buy Zydus Wellness Ltd For Target Rs.2,000 - ICICI Securities
Buy Zydus Wellness Ltd For Target Rs.2,000 - ICICI Securities
Source: ICICI Securities Ltd
12/12/2022 9:26:00 AM
Buy Zydus Wellness Ltd For Target Rs.2100 - ICICI Direct Strong recovery led by summer brands About the stock: Zydus Wellness (ZWL) is one of the FMCG companies present in healthcare, nutrition & related products. The company has six brands i.e. Sugarfree, Complan, Glucon-D, Nycil, Everyuth & Nutrilite * It commands dominant market share in Sugar substitute (96%), Prickly heat powder (34.2%) & Glucose powder (60.4%) categories * The company has more than 850 distributors with direct reach of 0.6 million retail outlets. Its high...
Buy Zydus Wellness Ltd For Target Rs.2100 - ICICI Direct
Buy Zydus Wellness Ltd For Target Rs.2100 - ICICI Direct
Source: ICICI Direct Ltd
8/10/2022 10:12:19 AM
Add Zydus Wellness Ltd For Target Rs.1,858 - Yes Securities Improved quarter performance led by market share gains; maintain ADD Our view Q1 performance was quite encouraging on the growth fronts led by 10.3% volume growth and sequential market share gains in key brands GluconD, Nycil and Everyuth. Complan and Sugar Free continue to struggle since last few quarters due to category decline and less aggression in distribution expansion. Timely price hikes in Q4 also aided gross margin contraction to only 110bps. Few positives were strong double di...
Add Zydus Wellness Ltd For Target Rs.1,858 - Yes Securities
Add Zydus Wellness Ltd For Target Rs.1,858 - Yes Securities
Source: Yes Securities Ltd
26/08/2022 11:59:42 AM
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance Zydus Wellness Ltd. (ZWL) recently announced its performance for the quarter ended June 30, 2022. The company posted a healthy set of numbers backed by strong growth in summer season brands Glucon-D & Nycil, coupled with price rises. Following are the key highlights. Highlights from Q1 FY23 * During the quarter, the top-line grew by 16.6% YoY to Rs.696.8 cr; on sequential basis, the turnover jumped 8.9% QoQ; the net sales recorded an increase of 17.8% (volume growth 10.3%). * Acc...
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Source: Sushil Finance Ltd
1/08/2022 1:28:32 PM
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance Zydus Wellness Ltd. (ZWL) recently announced its performance for the quarter ended March 31, 2022. The top-line & EBITDA were in-line with our estimates & bottom-line was moderately above our estimate. Following are the key highlights. Highlights from Q4 FY22 & FY22 * During the quarter, the top-line grew by 5.6% (volume growth 0.4%) and during the fiscal ended March 31, 2022, the top-line grew by 7.3% (volume growth 2.3%). The Management stated that the company has taken a ...
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Buy For Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Source: Sushil Finance Ltd
19/05/2022 10:34:05 AM
Add Zydus Wellness Ltd : Weakness persists on both growth and margin fronts; downgrade to ADD despite structural positives - Yes Securities Add For Zydus Wellness Ltd Target Rs.1,858 Weakness persists on both growth and margin fronts; downgrade to ADD despite structural positives Our view Q4 performance was quite disappointing both on the growth and margin fronts despite price hikes taken given sequential market share losses in key brands Complan, Sugar Free and Nycil leading to an inferior product mix. Complan and Sugar Free continue to struggle since last few quarters due to category decline and less aggression in dis...
Add Zydus Wellness Ltd : Weakness persists on both growth and margin fronts; downgrade to ADD despite structural positives - Yes Securities
Add Zydus Wellness Ltd : Weakness persists on both growth and margin fronts; downgrade to ADD despite structural positives - Yes Securities
Source: Yes Securities Ltd
18/05/2022 2:25:21 PM
Buy Zydus Wellness Ltd For Target Rs.2,250 - ICICI Securities Weak execution; however, distribution (expansion) and product strategy (appears to be) in place Q3FY22 was a weak quarter with 2% YoY revenue growth (8.7% on 2-year CAGR basis). Product mix (inferior) and high raw material costs continued to impact margins – EBITDA margin shrank 467bps YoY to 8.3%. We continue to believe that the acquisition of Heinz India business is transformational for Zydus, given the increased consumer focus on health and wellness – likely accelerated c...
Buy Zydus Wellness Ltd For Target Rs.2,250 - ICICI Securities
Buy Zydus Wellness Ltd For Target Rs.2,250 - ICICI Securities
Source: ICICI Securities Ltd
25/02/2022 1:22:38 PM
Buy Zydus Wellness Ltd For Target Rs.2200 - ICICI Direct Slower growth with trade inventory rationalisation About the stock: Zydus Wellness (ZWL) is one of the FMCG companies present in healthcare, nutrition & related products. The company has six brands i.e. Sugarfree, Complan, Glucon-D, Nycil, Everyuth & Nutrilite It commands dominant market share in sugar substitute (96%), prickly heat powder (34%) & glucose powder (58.1%) categories The company has more than 850 distributors with direct reach of 0.55 million retail outlets....
Buy Zydus Wellness Ltd For Target Rs.2200 - ICICI Direct
Buy Zydus Wellness Ltd For Target Rs.2200 - ICICI Direct
Source: ICICI Direct
22/02/2022 2:59:18 PM
Buy Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance Highlights from the Quarter (Q3 FY22): The demand during the seasonally weak quarter was further affected by impact of third wave of the pandemic resulting into the muted top-line growth. The Management also cited inventory correction actions taken at the distributors’ level as one of the reasons for flat sales. Further, the inflationary pressure on key raw materials and packaging materials continued to put pressure on the gross margins resulting into weaker than expected operating l...
Buy Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Buy Zydus Wellness Ltd Target Rs.2,520 - Sushil Finance
Source: Sushil Finance Ltd
4/02/2022 1:55:50 PM
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct High commodity prices to keep margins under check About the stock: Zydus Wellness (ZWL) is one of the FMCG companies present in healthcare, nutrition & related products. The company has six brands i.e. Sugarfree, Complan, Glucon-D, Nycil, Everyuth & Nutrilite. * It commands dominant market share in sugar substitute (96%), prickly heat powder (34.5%) & glucose powder (58.3%) categories * The company has more than 1700 distributors with direct reach of 0.55 million retail o...
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct
Source: ICICI Direct
2/12/2021 10:48:36 AM
Buy Zydus Wellness Ltd For Target Rs.2,502 - Yes Securities Margin headwinds remain but consistent double-digit growth delivery keeps us positive; maintain BUY Our view While Q2 performance was disappointing on the margins front, a strong 12% revenue growth with volume growth of 8% indicates strength of the brands and improved execution by the company. Consistent double-digit growth in Complan and Everyuth with market share gains and enhanced proposition launched during Q2 exhibits management’s focus to leverage the brand equity and furthe...
Buy Zydus Wellness Ltd For Target Rs.2,502 - Yes Securities
Buy Zydus Wellness Ltd For Target Rs.2,502 - Yes Securities
Source: Yes Securities Ltd
17/11/2021 12:25:42 PM
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance Zydus Wellness Ltd. recently announced its performance for the quarter ended September 30, 2021. Following are the key highlights Highlights from the Quarter (Q2 FY22): The second quarter of the fiscal which happens to be a seasonally weak quarter was further affected by poor season and limited consumer mobility because of second wave of covid. The glucose powder and prickly heat powder categories were particularly impacted by adverse weather condition and early monsoon. Nevertheless, s...
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance
Source: Sushil Finance Ltd
30/10/2021 10:22:40 AM
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities Good 1QFY22 with improving margin trajectory (could've been better though) Q1FY22 was decent with broad-based growth across brands. Expansion in ecommerce and improving international business is positive. We continue to believe that the acquisition of Heinz India business is transformational for Zydus, given the increased consumer focus on health and wellness – likely accelerated consumer adoption of >70% of the portfolio (Sugar Free, Glucon-D, Nutralite and Complan). We es...
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities
Source: ICICI Securities
8/09/2021 10:49:46 AM
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct Second Covid-19 wave drags sales… About the stock: Zydus Wellness (ZWL) is one of the FMCG companies present in healthcare, nutrition & related products. The company has six brands i.e. Sugarfree, Complan, Glucon-D, Nycil, Everyuth and Nutralite. * It commands a dominant market share in sugar substitute (93%), prickly heat powder (35.8%) & glucose powder (58.4%) categories. * The company has more than 1700 distributors with direct reach of 0.55 million retail outlets. ...
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct
Buy Zydus Wellness Ltd For Target Rs.2800 - ICICI Direct
Source: ICICI Direct
7/09/2021 12:55:25 PM
MTF Stock Pick Buy Zydus Wellness Ltd For Target Rs. 2586 - HDFC Securities MTF Stock Pick Buy Zydus Wellness Ltd For Target Rs. 2586 - HDFC Securities  TECHNICAL OBSERVATIONS ZYDUSWELL is in strong uptrend on Major time frame. After making a life high on 27th April 2021 it started correcting and halted near 1985 levels which also coincide with bullish trend line. Today stock has broken out from ascending triangle on the daily time frame which is bullish continuation pattern. It also took multiple support of bullish trend line and...
MTF Stock Pick Buy Zydus Wellness Ltd For Target Rs. 2586 - HDFC Securities
MTF Stock Pick Buy Zydus Wellness Ltd For Target Rs. 2586 - HDFC Securities
Source: HDFC Securities Ltd
26/08/2021 1:32:17 PM
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance Leadership position in the key brands & consistent innovations to drive the growth: ZWL is an undisputed market leader in various niche categories such as sugar-substitutes (Sugar Free–93.0%), scrubs (Everyuth–35.8%), peel-offs (Everyuth– 77.0%), glucose powder (Glucon–D, 58.4%), prickly heat powder (Nycil–35.4%); 11 new products were launched during FY21.   Widening geographical presence & share of overseas businesses: ZWL has planned to enter...
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance
Buy Zydus Wellness Ltd For Target Rs.2,700 - Sushil Finance
Source: Sushil Finance Ltd
30/06/2021 9:13:10 AM
Buy Zydus Wellness Ltd For Target Rs. 2800 - ICICI Direct Robust growth; margins to expand… Zydus Wellness (ZWL) reported healthy results with revenue growth of 24.2% due to ~| 100 crore sales loss in base quarter due to lockdown imposed in March 2020. The company witnessed strong double digit growth in Sugar Free & Nycil. Further, discretionary brand Everyuth also saw strong growth with an increase in out of home activity. HORECA dominant brand like Nutralite saw a sharp recovery with sales reaching at pre-Covid levels in Q4. ZWL m...
Buy Zydus Wellness Ltd For Target Rs. 2800 - ICICI Direct
Buy Zydus Wellness Ltd For Target Rs. 2800 - ICICI Direct
Source: ICICI Direct
2/06/2021 11:39:13 AM
Zydus & TLC sign agreement to market critical drug to treat Black Fungus Zydus and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC is a critical drug to treat Mucormycosis or Black Fungus in India. Under the terms of the agreement, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to Zydus, and Zydus will commercialize AmphoTLC in India. The Central Drugs Standard Control ...
Zydus & TLC sign agreement to market critical drug to treat Black Fungus
Zydus & TLC sign agreement to market critical drug to treat Black Fungus
Source: IANS
26/05/2021 1:55:03 PM
Buy Zydus Wellness Ltd For Target Rs. 2,500 - ICICI Securities Symphony; retain top pick status Q4 performance was impressive with double digit-growth (on 2-year CAGR as well) across brands except for Glucon-D which was impacted due to delayed onset of summer season. We believe the acquisition of Heinz India business is transformational for Zydus, given the increased consumer focus on health and wellness – likely accelerated consumer adoption of >70% of the portfolio (Sugar Free, Glucon-D, Nutralite and Complan). We especially like the new...
Buy Zydus Wellness Ltd For Target Rs. 2,500 - ICICI Securities
Buy Zydus Wellness Ltd For Target Rs. 2,500 - ICICI Securities
Source: ICICI Securities Ltd
25/05/2021 11:53:13 AM
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities Good 3Q; Broad-based performance Q3 witnessed continued growth as gross revenue grew 16% (volume-led), driven by broad-based strong brand performance. We believe the acquisition of Heinz India business is transformational for Zydus Wellness, given the increased consumer focus (COVID-led) on health and wellness – likely accelerated consumer adoption of >70% of the portfolio (Sugar Free, Glucon-D, Nutralite and Complan). We especially like – (1) the new product development st...
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities
Buy Zydus Wellness Ltd For Target Rs.2,500 - ICICI Securities
Source: ICICI Securities Ltd
3/02/2021 10:29:37 AM